AINewsnow

Remedy Robotics Raises $62M Series B for AI-Enabled Robotic Intervention Platform

This story is from 2026-11-16. It is preserved in the archive; the latest stories are on the live feed.

Remedy Robotics announced on November 16, 2026 a $62 million Series B round to advance clinical development and planned deployment of N1, its AI-enabled robotic platform for cardiovascular and neurovascular procedures, toward clinical trials and potential FDA approval.

Read the full story at Unite.AI ↗

Timeline · 2 reports

  1. 2026-11-17 09:36 · AI Insider
    Remedy Robotics Raises $62M in Series B Funding to Advance AI-Enabled Vascular Intervention System
  2. 2026-11-16 15:30 · Unite.AI
    Remedy Robotics Raises $62M Series B to Advance AI Cardiovascular Care

More stories

  1. Remedy Robotics Raises $62M Series B for AI-Enabled Vascular Intervention System — AI Insider
  2. Anthropic debuts on Wall Street in record $81.3 billion IPO, briefly hitting $2 trillion value — Anthropic (X)
  3. OpenAI launches GPT-6.2 Astra and Sol as Google ships Gemini 4 Neon and Microsoft unveils MAI Code 2 — OpenAI News
  4. Google launches Gemini 4 Neon and opens Genie 4 world model to Gemini API developers — Google DeepMind YouTube
  5. AWS expands SageMaker AI with data preparation tools and cross-Region inference routing — AWS Machine Learning Blog
  6. An early rally for Wall Street evaporates as the market waits for Anthropic's stock to begin trading — The Globe and Mail
  7. Google books Blue Origin's New Glenn for 2029 launch of AI server satellites — Google: The Keyword
  8. AWS expands SageMaker JumpStart with OpenTSLM, model leaderboard, and PolyAI Dialog-RSN-1 — AWS Machine Learning Blog

Read the Daily Brief: the day's most important AI stories →